Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 03/03/2015 1:41:02 PM
Post# of 30070
Posted By: Daveludlow
Re: zoomboom #17486
I'm located in an accurate understanding of what Dr. Urano has been telling us. I have always maintained that Urano will use our "recombinant MANF injections" to repair the eye damaged by wolframs/diabetes. This is consistent with AMBS' firm footing with the "Eye Franchise:" Retinitis, Glaucoma, Macular Degeneration.

I have also maintained that back in early 2014 Urano's focus on treating wolframs/diabetes was on "recombinant MANF injections." But, by September of 2014 Urano switched his preference away from "recombinant" to "small molecules" as a method of targeting the endogenous production of MANF within the body. (Which doesn't involve AMBS) He has reaffirmed his targeting of MANF from within the body as recently as 2 weeks ago.

For some reason you and several others here on the mb have consistently misunderstood this! This is not rocket science.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site